Novo Nordisk Showcases OASIS 4 Data Highlighting Broader Health Benefits of Oral Semaglutide 25 mg Read more
FDA Approves Johnson & Johnson’s DARZALEX FASPRO as First Treatment for High-Risk Smoldering Multiple Myeloma Read more
FDA Clears Jupiter Neurosciences’ IND to Launch Phase 2a Trial of JOTROL for Parkinson’s Disease Read more
Avant Technologies and SGAustria Form Joint Venture to Develop Stem Cell-Based Diabetes Therapy Read more
UCB Secures FDA Approval for KYGEVVI, the First-Ever Treatment for Ultra-Rare TK2 Deficiency Read more